Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma
Author:
Open Access
- 1 January 2012
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 18 (20) , 2540-4
Abstract
To study the expression of eukaryotic translation initiation factor 4E (eIF4E), which is closely correlated with malignant tumors, and its relationship to prognosis in hepatocellular carcinoma. Western blotting was performed to quantify the elF4E protein expression in the normal human liver cell line L02 and the hepatoma cell lines Hep3B, HepG2, and Huh7. Forty-six hepatocellular carcinoma samples with complete clinical data were obtained from Changzheng Hospital during the period of December 2008 to July 2009. The expression of eIF4E in the tumor samples and their adjacent tissues were detected by immunohistochemistry. The relationship between the test results and hepatocellular carcinoma (HCC) prognosis was statistically analysed by using a COX proportional hazard model. Western blotting analysis showed that there were distinct eIF4E protein bands in all three of the hepatoma cell lines. In particular, the HepG2 cell line had the highest level of eIF4E protein expression. The L02 cell group had a low eIF4E expression. Immunohistochemical assay showed that there were 32 cases in which the tumour tissue expression was higher than their adjacent tissues, accounting for 69.57%. There were also 14 cases in which the tumour tissue expression was lower or no significant difference was found, accounting for 30.43%. COX proportional hazards model analysis showed that HCC prognosis was related to the depth of invasion, the overexpression of eIF4E and p53, possibly as independent HCC prognostic predictors. In summary, eIF4E expression is associated with liver cancer, and patients with high eIF4E expression levels have a higher risk of recurrence.Keywords
This publication has 36 references indexed in Scilit:
- Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in CancerClinical Cancer Research, 2010
- Inhibition of eIF4E phosphorylation reduces cell growth and proliferation in primary central nervous system lymphoma cellsJournal of Neuro-Oncology, 2010
- Direct inhibition of eIF4E reduced cell growth in endometrial adenocarcinomaJournal of Cancer Research and Clinical Oncology, 2010
- Sumoylation of eIF4E activates mRNA translationEMBO Reports, 2010
- Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinomaLung Cancer, 2009
- Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcomeSurgery, 2009
- Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissuesCancer Biology & Therapy, 2009
- A Prospective Trial on Initiation Factor 4E (eIF4E) Overexpression and Cancer Recurrence in Node-Positive Breast CancerAnnals of Surgery, 2005
- Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancerOncogene, 1997
- Activation of mTOR in a subgroup of ovarian carcinomas: Correlation with p-eIF-4E and prognosisOncology Reports, 1994